David A Novis, MD | |
789 Central Ave, Dover, NH 03820-2526 | |
(603) 742-2132 | |
Not Available |
Full Name | David A Novis |
---|---|
Gender | Male |
Speciality | Pathology - Clinical Pathology/laboratory Medicine |
Location | 789 Central Ave, Dover, New Hampshire |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1164461158 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207ZP0105X | Pathology - Clinical Pathology/laboratory Medicine | 151475 (Massachusetts) | Primary |
Mailing Address | Practice Location Address |
---|---|
David A Novis, MD 18 Toon Ln, Lee, NH 03824-6507 Ph: (603) 742-2132 | David A Novis, MD 789 Central Ave, Dover, NH 03820-2526 Ph: (603) 742-2132 |
News Archive
Quantros, a leading provider of clinically-focused data management and decision support solutions for the healthcare industry, will demonstrate several new patient safety and risk management solutions at the American Society for Healthcare Risk Management (ASHRM) Annual Conference and Exhibition, to be held Oct. 13 to 16 in Tampa, FL.
A team co-led by a scientist at the University of California, Riverside, has developed a method to study how HIV mutates to escape the immune system in multiple individuals, which could inform HIV vaccine design.
A blood test to diagnose which heart attack survivors will suffer heart failure is the goal of a new five-year, $11.6 million contract to the UT Health Science Center San Antonio from the National Heart, Lung, and Blood Institute (NHLBI).
Aduro BioTech, Inc. announces the treatment of the first patient in the Phase 2 pancreatic cancer clinical trial of the sequential administration of two cancer vaccines: Aduro's CRS-207 and GVAX Pancreas Cancer Vaccine.
The Institute for Safe Medication Practices has announced that this year's George DiDomizio Industry Award is being presented to Intelliject, Inc. for pioneering advances in drug/device combination products with the Auvi-Q epinephrine auto-injector (also known as Allerject⢠in Canada). Auvi-Q is the first auto-injector with audio as well as visual cues for the emergency treatment of life-threatening allergic reactions.
› Verified 2 days ago
Glenn Harold Littell, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 789 Central Ave, Dover, NH 03820 Phone: 603-742-2132 | |
Dr. Polius Raslavicius, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 789 Central Ave, Wentworth-douglass Hospital, Dover, NH 03820 Phone: 603-335-2338 | |
Dr. Lucy Harn Kapur, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 789 Central Ave, Dover, NH 03820 Phone: 603-742-5252 |